Table 5.
Quantification of strength of COVID-19 treatment guidelines according to region and disease severity using an adapted metric based upon the July 2022 WHO guideline11
| Region | Therapeutic indication for non-severe disease Range: −14 to 21 |
Therapeutic indication for severe disease Range: −12 to 14 |
| AFR | −2.2 (±5.8) | 2.8 (±6.0) |
| AMR | 1.3 (±8.1) | 7.4 (±6.9) |
| SEAR | 6.3 (±7.0) | 7.4 (±3.7) |
| EUR | 8.1 (±6.8) | 8.1 (±4.3) |
| EMR | 0.82 (±3.4) | 3.5 (±6.6) |
| WPR | 7.25 (±10.3) | 5.8 (±4.8) |
Data are presented as mean (±SD).
AFR, African Region; AMR, Region of the Americas; EMR, Eastern Mediterranean Region; EUR, European Region; SEAR, South-East Asian Region; WPR, Western Pacific Region.